Safety, Tolerability and Effectiveness of Nuedexta in the Treatment of Pseudobulbar Affect (PBA)

Clinical trial NCT01799941 · COMPLETED

Trial details

NCT number: NCT01799941
Sponsor: Avanir Pharmaceuticals
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Pseudobulbar Affect (PBA)Stroke Dementia Traumatic Brain Injury (TBI)

Start date: 2013-02-01
Primary completion: 2015-05-01
Enrollment: 367

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.